Construction of cholera toxin B subunit-producing Vibrio cholerae strains using the Mariner-FRT transposon delivery system

FEMS Immunology and Medical Microbiology

Volumn 52, Issue 1, 2008, Pages 23-28

  Rhie, Gi Eun ^a   Jung, Hae Mi ^a   Park, Jungchan ^b   Kim, Bong Su ^a   Mekalanos, John J ^c  

^a Korea National Institute of Health   (South Korea)

^b Hankuk University of Foreign Studies   (South Korea)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cholera toxin B subunit; Cholera vaccine; Vibrio cholerae

Indexed keywords

CHOLERA TOXIN B SUBUNIT;

ARTICLE; BACTERIAL GENE; BACTERIAL IMMUNITY; BACTERIAL STRAIN; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELIVERY SYSTEM; GENE INSERTION SEQUENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSPOSON; VACCINE PRODUCTION; VIBRIO CHOLERAE;

CHOLERA TOXIN; DNA TRANSPOSABLE ELEMENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC VECTORS; MUTAGENESIS, INSERTIONAL; VIBRIO CHOLERAE O1;

EID: 38149030293     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2007.00346.x     Document Type: Article

References (31)

1. Chiang SL Mekalanos JJ (2000) Construction of a Vibrio cholerae vaccine candidate using transposon delivery and FLP recombinase-mediated excision. Infect Immun 68 : 6391 6397.
2. Chiang SL Rubin EJ (2002) Construction of a mariner-based transposon for epitope-tagging and genomic targeting. Gene 296 : 179 185.
3. Clemens JD, Sack DA, Harris JR et al 1986) Field trial of oral cholera vaccines in Bangladesh. Lancet 2 : 124 127.
4. Clemens JD, Sack DA, Harris JR et al 1990) Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet 335 : 270 273.
5. Coster TS, Killeen KP, Waldor MK, Beattie DT, Spriggs DR, Kenner JR, Trofa A, Sadoff JC, Mekalanos JJ Taylor DN (1995) Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype. Lancet 345 : 949 952.
6. Faruque SM, Albert MJ Mekalanos JJ (1998) Epidemiology, genetics and ecology of toxigenic Vibrio cholerae. Microbiol Mol Biol Rev 62 : 1301 1314.
7. Gardel CL Mekalanos JJ (1994) Regulation of cholera toxin by temperature, pH, and osmolarity. Methods Enzymol 235 : 517 526.
8. Heidelberg JF, Eisen JA, Nelson WC et al 2000) DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature 406 : 477 483.
9. Holmgren J, Osek J Svennerholm AM (1994) Protective oral cholera vaccine based on a combination of cholera toxin B subunit and inactivated cholera vibrios. Vibrio Cholerae and Cholera: Molecular to Global Perspectives (Wachsmuth IK, Blake PA Olsvik Ø, eds pp. 415 424. ASM Press, Washington, DC.
10. Holmgren J, Adamsson J, Anjuere F et al 2005) Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Immunol Lett 97 : 181 188.
11. John M, Crean TI, Calderwood SB Ryan ET (2000) In vitro and in vivo analyses of constitutive and in vivo-induced promoters in attenuated vaccine and vector strains of Vibrio cholerae. Infect Immun 68 : 1171 1175.
12. Kenner JR, Coster TS, Taylor DN et al 1995) Peru-15, an improved live, attenuated oral vaccine candidate for Vibrio cholerae O1. J Infect Dis 172 : 1126 1129.
13. Lencer WI Tsai B (2003) The intracellular voyage of cholera toxin: going retro. Trends Biochem Sci 28 : 639 645.
14. Levine MM, Kaper JB, Herrington D, Losonsky G, Morris JG, Clements ML, Black RE, Tall B Hall R (1988) Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun 56 : 161 167.
15. McKenzie SJ Halsey JF (1984) Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response. J Immunol 133 : 1818 1824.
16. Mekalanos JJ, Moseley SL, Murphy JR Falkow S (1982) Isolation of enterotoxin structural gene deletion mutations in Vibrio cholerae induced by two mutagenic vibriophages. Proc Natl Acad Sci USA 79 : 151 155.
17. Mekalanos JJ, Swartz DJ, Pearson GD, Harford N, Groyne F de Wilde M (1983) Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development. Nature 306 : 551 557.
18. Miller VL Mekalanos JJ (1988) A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol 170 : 2575 2583.
19. Osorio CG, Martinez-Wilson H Camilli A (2004) The ompU paralogue vca 1008 is required for virulence of Vibrio cholerae. J Bacteriol 186 : 5167 5171.
20. Qadri F Chowdhury MI, Peru-15 Study Group et al 2005) Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh. J Infect Dis 192 : 573 579.
21. Qadri F Chowdhury MI, the PXV Study Group et al 2007) Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants. Vaccine 25 : 231 238.
22. Rubin EJ, Akerley BJ, Novik VN, Lampe DJ, Husson RN Mekalanos JJ (1999) In vivo transposition of mariner-based elements in enteric bacteria and mycobacteria. Proc Natl Acad Sci USA 96 : 1645 1650.
23. Ryan ET, Butterton JR, Zhang T, Baker MA, Stanley JR SL Calderwood SB (1997) Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice. Infect Immun 65 : 3118 3125.
24. Sanchez J Holmgren J (1989) Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development. Proc Natl Acad Sci USA 86 : 481 485.
25. Sandkvist M, Bagdasarian M, Howard SP Dirita VJ (1995) Interaction between the autokinase EpsE and EpsL in the cytoplasmic membrane is required for extracellular secretion in Vibrio cholerae. EMBO J 14 : 1664 1673.
26. Simons R, Priefer U Pühler A (1983) A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram negative bacteria. Bio/Technology 1 : 784 791.
27. Slos P, Speck D, Accart N, Kolbe HV, Schubnel D, Bouchon B, Bischoff R Kieny MP (1994) Recombinant cholera toxin B subunit in Escherichia coli: high-level secretion, purification, and charaterization. Protein Express Purif 5 : 518 526.
28. Spangler BD (1992) Structure and function of cholera toxin and the related Escherichia coli heat-liabile enterotoxin. Microbiol Rev 56 : 622 647.
29. Tendeng C, Badaut C, Krin E, Gounon P, Ngo S, Danchin A, Rimsky S Bertin P (2000) Isolation and characterization of vicH, encoding a new pleiotropic regulator in Vibrio cholerae. J Bacteriol 182 : 2026 2032.
30. Xu Q, Dziejman M Mekalanos JJ (2003) Determination of the transcriptome of Vibrio cholerae during intraintestinal growth and midexponential phase in vitro. Proc Natl Acad Sci USA 100 : 1286 1291.
31. Yasuda Y, Matano K, Asai T Tochikubo K (1998) Affinity purification of recombinant cholera toxin B subunit oligomer expressed in Bacillus brevis for potential human use as a mucosal adjuvant. FEMS Immun Med Microbiol 20 : 311 318.